Researchers find that increase of 'CLU' protein promotes brain resilience and could provide protection from Alzheimer's disease
Recently approved Alzheimer's drugs offer a step forward for treating the disease, but new therapeutic strategies are needed to complement them and provide personalized therapeutic approaches. Researchers have identified a potential strategy to protect against Alzheimer's disease by increasing the clusterin protein (CLU).
